Literature DB >> 12271805

Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors.

A P Morrison1, R P Bentall, P French, L Walford, A Kilcommons, A Knight, M Kreutz, S W Lewis.   

Abstract

BACKGROUND: There is interest in the possibility of indicated prevention of psychosis. There is a strong case for using psychological approaches to prevent transition to psychosis in high-risk patients. AIMS: To identify individuals at high risk of transition to psychosis, and psychological characteristics relevant to the development of psychosis in this group.
METHOD: The design of a randomised controlled trial of cognitive therapy for the prevention of psychosis in people at high risk (meeting operational criteria of brief or attenuated psychotic symptoms, or first-degree family history with functional decline) is outlined. The first patients recruited are compared with non-patient samples on cognitive and personality factors; an interim analysis of transition rate is reported.
RESULTS: Cases (n = 31) were recruited mainly from primary care. Of the 23 high-risk patients monitored for 6-12 months, 5 (22%) made the transition to psychosis. The high-risk group scored significantly higher than non-patients on measures of schizotypy, metacognitive beliefs and dysfunctional self-schemas (sociotropy).
CONCLUSIONS: The findings validate the methods of identifying individuals at high risk of experiencing a psychotic episode. Compared with non-patient controls, the cases showed dysfunctional metacognitive beliefs and self-schemas.

Entities:  

Mesh:

Year:  2002        PMID: 12271805     DOI: 10.1192/bjp.181.43.s78

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  17 in total

1.  Missing the sweet spot disengagement in schizophrenia.

Authors:  Richard S E Keefe
Journal:  Psychiatry (Edgmont)       Date:  2006-07

2.  The future of psychological therapies for psychosis.

Authors:  Philippa A Garety
Journal:  World Psychiatry       Date:  2003-10       Impact factor: 49.548

Review 3.  [Early recognition and intervention for schizophrenia].

Authors:  N Mossaheb; G Wiesegger; G P Amminger; S Kasper; J Tauscher
Journal:  Nervenarzt       Date:  2006-01       Impact factor: 1.214

Review 4.  The assessment of schizotypy and its clinical relevance.

Authors:  Oliver J Mason
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

Review 5.  Early intervention for psychosis.

Authors:  Max Marshall; John Rathbone
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

Review 6.  Antipsychotic medication for early episode schizophrenia.

Authors:  John Bola; Dennis Kao; Haluk Soydan
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

7.  Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?

Authors:  Alison R Yung; Hok Pan Yuen; Gregor Berger; Shona Francey; Te-Chieh Hung; Barnaby Nelson; Lisa Phillips; Patrick McGorry
Journal:  Schizophr Bull       Date:  2007-04-02       Impact factor: 9.306

Review 8.  Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia.

Authors:  Christopher Jones; David Hacker; Irene Cormac; Alan Meaden; Claire B Irving
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 9.  The early identification of psychosis: can lessons be learnt from cardiac stress testing?

Authors:  Swapnil Gupta; Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2015-11-14       Impact factor: 4.530

10.  Computerized Assessment of Psychosis Risk.

Authors:  Vijay A Mittal; Lauren M Ellman; Gregory P Strauss; Elaine F Walker; Philip R Corlett; Jason Schiffman; Scott W Woods; Albert R Powers; Steven M Silverstein; James A Waltz; Richard Zinbarg; Shuo Chen; Trevor Williams; Joshua Kenney; James M Gold
Journal:  J Psychiatr Brain Sci       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.